Stock Events

Stock Events

Search...

Regulus Therapeutics (RGLS) Q4 2023 Earnings

21MarConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.44

-0.42

-0.39

-0.37

Details

Expected EPS

-0.39

Actual EPS

-0.4

Surprise EPS

-0.01

Surprise Percent

+2.56%

Description

Regulus Therapeutics (RGLS) has reported earnings of -0.4 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.